Labshake search
Citations for R&D Systems :
1 - 50 of 3412 citations for Methylphosphonic Acid 13C 99%; Methyl D3 98% 100 Ug Ml In Methanol since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Bioengineering 2023Quote: ... or 100 ug/mL NRP-1 Antibody (R&D Systems) every other day for 5 days.
-
bioRxiv - Cancer Biology 2022Quote: ... The following neutralizing antibodies were used: anti-CXCL12 (R&D systems, clone 79014, 100 ug/ml) and anti-CXCL2 (Thermo Fisher ...
-
bioRxiv - Neuroscience 2024Quote: ... agrin (R&D Systems; 0.1 ug/mL) was added (Sup ...
-
bioRxiv - Cell Biology 2023Quote: ... supplemented with FGF2 (4 ug/mL; Biochemistry Department, University of Cambridge) and TGF-β1 (1.74 ug/mL; R&D Systems) using Vitronectin XF (STEMCELL Technologies ...
-
bioRxiv - Neuroscience 2021Quote: ... Capture antibody (R&D Systems, BAF1729, 0.25 ug/ml) was applied at RT for 1 hour ...
-
bioRxiv - Cell Biology 2021Quote: ... CTSD (1 ug/mL, R&D Systems cat. no. AF1014), β-actin (1:1000 ...
-
bioRxiv - Bioengineering 2022Quote: ... IgG1 antibody control (30 ug/mL, R&D Systems, MAB002), ICAM-1/CD54 (10ug/mL ...
-
bioRxiv - Neuroscience 2023Quote: ... Sigma P4957)/laminin (10 ug/mL, R&D Systems 3400-010-02) and subsequent manual rosette selection and expansion ...
-
bioRxiv - Microbiology 2022Quote: ... and 2 ug/mL of MetAP enzyme (R&D Systems 3537-ZN). Product detection,each reaction well is supplemented with 25 uL of 2 ng/mL DPPIV/CD26 (serine exopeptidase diluted in activation buffer).
-
bioRxiv - Immunology 2021Quote: ... Blocking of ACE2 was performed with 8 ug/mL anti-ACE2 (R&D systems) for 30 min at 37°C before adding stimuli ...
-
bioRxiv - Microbiology 2023Quote: ... or 3 ug/ml of an anti-Dectin-1 antibody (MAB1859; R&D Systems). Mouse IgG was used as a control ...
-
bioRxiv - Bioengineering 2020Quote: ... 100 μl of stop solution (Sulfuric acid) (R&D systems) was added ...
-
bioRxiv - Cancer Biology 2021Quote: ... and 100 U/mL rmIL-2 (402-ML-100, R&D Systems) in the presence of increasing concentrations of SU11652 (sc-204310 ...
-
bioRxiv - Immunology 2021Quote: ... or 5 ug/ml isotype or neutralizing monoclonal anti-hIL-33 antibodies (R&D Systems, MAB36254), followed by stimulation with rIL-33 (Peprotech) ...
-
bioRxiv - Neuroscience 2020Quote: ... Primary antibodies used for immunoblotting were sheep anti-DRAXIN (AF6149, R&D systems, 1 ug/mL), goat anti-β-ACTIN (AB0145-200 ...
-
bioRxiv - Microbiology 2023Quote: FimHLD (40 ug/mL) was incubated with serial dilutions of HMGB1 recombinant protein (R&D systems) for 1 hour at room temperature ...
-
bioRxiv - Bioengineering 2023Quote: ... B cell activating medium was supplemented with 5 ug/mL anti-CD40 antibody (R&D systems) and 20 ng/mL IL-4 (R&D Systems ...
-
bioRxiv - Immunology 2023Quote: ... PBMCs were cultured for 8 days and stimulated with 2.5 ng/mL crude peanut extract (Stallergenes Greer) with or without 50 ug/mL anti-human IL-4Ra (R&D Systems), as previously described (17).
-
bioRxiv - Cell Biology 2019Quote: ... 2 ug/ml Doxycycline and 3.34 ug/ml Puromycin, 1 × N27 supplement, and 10 ng/ml BDNF (STEMCELL, 78005) and GDNF (R&D Systems, 212-GD)) ...
-
bioRxiv - Immunology 2024Quote: ... treated with 100 ng/mL IL-1β (R&D Systems, #401-ML-005, 100 µg/mL stock in PBS) and 50 ng/mL TNF (R&D Systems ...
-
bioRxiv - Cancer Biology 2022Quote: ... 100 ng/ml Noggin(R&D Systems # 6057-NG-100), 500 nM A83-01 (Tocris # 2939) ...
-
bioRxiv - Cancer Biology 2023Quote: ... 40ng/mL recombinant human FGF (R&D systems, 100-18B-100), 0.5 × B27 serum free supplement (ThermoFisher Scientific ...
-
bioRxiv - Bioengineering 2020Quote: ... The slides were fixed in an ice-cold acetone/methanol mixture (50%/50%) and stained with primary anti-mouse CD144 antibody (MAB9381, 1:100, R&D Systems) and secondary donkey-anti-mouse Alexa Fluor® 594 (A21203 ...
-
bioRxiv - Immunology 2024Quote: ... Mice were injected with 100 ng/mL IL-1β (R&D Systems, #401-ML-005, 100 µg/mL stock in PBS) and 50 ng/mL TNF (R&D Systems ...
-
bioRxiv - Immunology 2024Quote: ... Primary astrocytes were treated with 100 ng/mL IL-1β (R&D Systems, #401-ML-005, 100 µg/mL stock in PBS) and 50 ng/mL TNF (R&D Systems ...
-
bioRxiv - Cell Biology 2020Quote: Tiam1 (R&D Systems, AF5038, sheep 1:200, methanol)
-
bioRxiv - Neuroscience 2022Quote: ... DIV12 hippocampal neurons were treated with either 2 ug/mL of recombinant Nptx2 (CF 7816-NP-050, R&D Systems) or BSA as control ...
-
bioRxiv - Developmental Biology 2021Quote: ... 100 ng/ml GDF7 (R&D Systems). Depending on culture conditions used ...
-
bioRxiv - Developmental Biology 2021Quote: ... 100 ng/ml WNT3a (R&D Systems), 6 μM CHIR99021 (EMD Millipore ...
-
bioRxiv - Cancer Biology 2019Quote: ... 100 ng/ml FGF1 (R&D Systems), 100 ng/ml IGF1 (R&D Systems) ...
-
bioRxiv - Cancer Biology 2019Quote: ... 100 ng/ml IGF1 (R&D Systems), 100 ng/ml HGF (R&D Systems) ...
-
bioRxiv - Cancer Biology 2019Quote: ... 100 ng/ml HGF (R&D Systems), 1 ng/ml TGFβ1 (Sigma-Aldrich ...
-
bioRxiv - Cancer Biology 2019Quote: ... 100 ng/ml SDF1α (R&D Systems), or conditioned medium collected from mesenchymal stem cells to stimulate reactivation and growth ...
-
bioRxiv - Cancer Biology 2019Quote: ... 100 ng/ml FGF1 (R&D Systems), 100 ng/ml TGFβ1 (R&D Systems) ...
-
bioRxiv - Cancer Biology 2019Quote: ... 100 ng/ml TGFβ1 (R&D Systems). In addition ...
-
bioRxiv - Developmental Biology 2019Quote: ... 100 ng/ml BMP7 (R&D Systems) and 1 μg/ml Heparin (Sigma-Aldrich) ...
-
bioRxiv - Developmental Biology 2019Quote: ... SCF (100 ng/ml; R&D Systems), and EGF (50 ng/ml ...
-
bioRxiv - Cell Biology 2022Quote: ... 100 ng/mL Shh (R&D systems) and 5% FBS for 14 days with media changes every seven days.
-
bioRxiv - Developmental Biology 2019Quote: ... mEGF (100 ng/mL; R&D Systems), 1 mM L-glutamine (Invitrogen) ...
-
bioRxiv - Developmental Biology 2019Quote: ... bFGF (R&D Systems, 100 ng/ml) and rGDNF (R&D Systems ...
-
bioRxiv - Cancer Biology 2021Quote: ... 100 ng/ml FGF2 (R&D Systems), 1 mM N-Acetyl-L-cysteine (Sigma Aldrich ...
-
bioRxiv - Cell Biology 2020Quote: ... 100 ng/mL FGF8 (R&D Systems) and 1 μM PMA ...
-
bioRxiv - Developmental Biology 2022Quote: ... 100 ng/ml SCF (R&D systems), 50 ng/ml EGF (R&D Systems) ...
-
bioRxiv - Developmental Biology 2022Quote: ... Wnt3a (100 ng/ml, R&D systems, cells were incubated in serum-free medium for 20 hours ...
-
bioRxiv - Microbiology 2023Quote: ... 100 ng/mL noggin (R&D systems), 50 ng/mL recombinant human EGF (R&D systems) ...
-
bioRxiv - Immunology 2023Quote: ... LPS (100 µg/ml, R&D systems), fMLP (100 nM) ...
-
bioRxiv - Microbiology 2023Quote: ... 100 ng/mL Noggin (R&D systems), 50 ng/mL recombinant human EGF (R&D systems) ...
-
bioRxiv - Developmental Biology 2023Quote: ... 100 ng/ml hEGF (R&D Systems) and 50 ng/ml FGF10 (R&D Systems) ...
-
bioRxiv - Cancer Biology 2023Quote: ... SCF (100 ng/ml, R&D Systems) and TPO (20 ng/ml ...
-
bioRxiv - Cancer Biology 2023Quote: ... SCF (100 ng/ml, R&D Systems) and TPO (20 ng/ml ...